When was seqWell founded?

seqWell was founded in 2014 and raised its 1st funding round 2 years after it was founded.

Where is seqWell located?

seqWell is headquartered in Beverly, United States. It is registered at Beverly, Massachusetts.

How many employees does seqWell have?

As of Aug 31, 2026, the latest employee count at seqWell is 36.

Is seqWell a funded company?

seqWell is a funded company, having raised a total of $24.5M across 6 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Jul 15, 2016.

When was the latest funding round of seqWell?

seqWell's latest funding was a $***** Series C round on Sep 16, 2024, with participation from 0 investor.

Where does seqWell rank among its competitors?

seqWell ranks 2nd amongst 129 active competitors, of which 25 are funded. It stands 3rd in terms of total funding among its competitors. The most recent competitor to raise funding was RareCyte, which secured $658K in May, 2025.

Who are the top competitors of seqWell?

seqWell's top competitors include LGC, RareCyte and Neogen. Among them, RareCyte secured the most recent funding round in May, 2025.

seqWell - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of NGS-based reagents and kits for life sciences research. The company has developed a plexWell platform, transformative technology for parallelized library prep that allows for simple, easy multiplexing of 100s to 1000s of distinct samples. The company's Illumina-compatible plexWell Library Preparation technology permits an order-of-magnitude improvement in the number of samples that can be prepared and readily sequenced on benchtop NGS instruments.

Website: seqwell.com
Social
Registered Address: Beverly, Massachusetts

Key Metrics

Founded Year

2014

Location

Beverly, United States

Stage

Series C

Total Funding

$24.5M in 6 rounds

Latest Funding Round

Series C, Sep 16, 2024, $*****

Investors

RCT & 4 more

Ranked

2^nd among 129 active competitors

Employee Count

36 as on Aug 31, 2026

Similar Companies

LGC & 152 more

View seqWell's full profile

seqWell is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Seqwell, Inc. CIN: 464755914 , United States, Active	Dec 31, 1999	-	30 (As on Dec 31, 2024)	-

seqWell has raised a total funding of $24.5M over 6 rounds. Its first funding round was on Jul 15, 2016. seqWell has 5 institutional investors.

Here is the list of recent funding rounds of seqWell:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Sep 16, 2024	5849774	Series C	3713507	9484700	8614581	6756977
Sep 11, 2023	4415937	Series C	4482137	4623762	1135547	8910025
Apr 21, 2022	7935896	Series C	2323807	8137476	Codexis	Broadoak Capital Partners & 1 more

Access funding benchmarks and valuations. Sign up today!

View details of seqWell's funding rounds and investors

The founders of seqWell are Jack Leonard and Joseph Mellor.

Here are the details of seqWell's key team members:

Jack Leonard: Co-Founder & CTO of seqWell.
Contact Info: 1 email address
Joseph Mellor: Founder & CEO of seqWell.

View details of seqWell's Founder profiles and Board Members

seqWell's employee count trend

seqWell has 36 employees as of Aug 26. Here is seqWell's employee count trend over the years:

Uncover seqWell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of seqWell include LGC, RareCyte and Neogen. Here is the list of Top 10 competitors of seqWell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	LGC 1842, Teddington (United Kingdom), Acquired	Provider of analytical testing, reference materials, and diagnostic and therapeutic products	-	Broad Vision Funds, AlpInvest Partners & 4 others	65/100
2nd	seqWell 2014, Beverly (United States), Series C	Provider of NGS-based reagents and kits for life sciences research	$24.5M	CYwP Funds, Broadoak Capital Partners & 3 others	60/100
3rd	RareCyte 2009, Seattle (United States), Series C	Developer of technologies for the analysis of rare and single cells in the blood	$114M	Arboretum Ventures, Health Quest Capital ... & 11 others	57/100
4th	Neogen 1982, Lansing (United States), Acquired	Solutions for food and animal safety, diagnostics, and genomics	$700K	Innovative Ventures, NISA	56/100
5th	Genomtec 2016, Wroclaw (Poland), Series A	Provider of handheld POC device for nucleic acid testing	$4.38M	KnowledgeHub, EIC Fund & 5 others	55/100
6th	Paragon Genomics 2015, San Francisco (United States), Series A	Provider of technologies and solutions genomic research and precision medicine	$8M	Fosun·Star Future Capital, Co-win Ventures ... & 3 others	51/100
7th	Novacyt 2005, Velizy Villacoublay (France), Public	A molecular diagnostics company specializing in genomic medicine solutions	-	Kreos Capital, Eiffel Investment Group & 2 others	50/100
8th	Lexogen 2007, Vienna (Austria), Late Stage	Provider of kits and software that enable detailed analysis of the complete transcriptome	-	FFG, Vienna Business Agency & 1 others	47/100
9th	NimbleGen 1999, Basel (Switzerland), Acquired	NGS solutions for research applications	$31.4M	Skyline Ventures, Cargill Ventures & 9 others	47/100
10th	ProteoNic 2007, Leiden (Netherlands), Series A	Provider of products and services for improving recombinant protein production levels	$8.13M	fairbanksfund.com	45/100